drugset / Trial / NCT00939133

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

NCT00939133

Phase 4 Completed 20 enrolled Dermatrials Research Johnson & Johnson · collab
RandomizedSingle-groupTriple-blindPrevention

Summary

The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.

Timeline

Start
2009-07
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tretinoin Small molecule 0.04 % Topical

Indications